The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated ...
The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and biologics by publishing its first provisional guidance on the technology's ...
The FDA has launched the Chemical Contaminants Transparency Tool, a searchable database providing detailed information on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback